TFFP TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc. operates as an early-stage biopharmaceutical company. It develops and commercializes drug products based on its Thin film Freezing (TFF) technology platform. The firm also engages in research, development & drug formulation and initial testing of drug products. The company was founded in 2005 and is headquartered in Toronto, Canada.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/25/2019
Outstanding shares:  25,371,781
Average volume:  216,796
Market cap:   $185,721,437
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    87241J104
ISIN:        US87241J1043
Sedol:      BKTN054
Valuation   (See tab for details)
PE ratio:   -12.49
PB ratio:   3.76
PS ratio:   0.00
Return on equity:   -38.15%
Net income %:   -23,912,810.37%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy